20 July 2021

The COVAX No Fault Compensation Programme: Explained

Indemnity and liability was one of the thorniest problems COVAX had to solve to successfully roll out COVID-19 vaccines in lower-income countries. The solution is a world first, which could offer a model for future pandemics.

26 April 2021

The Zero-Dose Child: Explained

Despite decades of progress increasing access to immunisation in lower-income countries, nearly 10 million children still go without basic, routine vaccines every year. Gavi, the Vaccine Alliance is now focusing on reaching these zero-dose children.

30 March 2021

The COVAX Humanitarian Buffer Explained

COVAX was designed to ensure the most vulnerable in every country get access to COVID-19 vaccines. But what about people in conflict zones or humanitarian settings that can’t be reached by government vaccination campaigns? Last week Gavi approved a ‘Humanitarian Buffer’ to ensure no one is left behind. Here’s how it works.

15 February 2021

The Gavi COVAX AMC Explained

Gavi’s CEO explains how the COVAX Advance Market Commitment mechanism will make COVID-19 vaccines available to lower-income countries.

13 November 2020

COVAX Facility governance explained

How will the COVAX Facility ensure equitable access to COVID-19 vaccines is indeed equitable? By Aurélia Nguyen, Managing Director, Office of the COVAX Facility

3 September 2020

COVAX explained

To end this global health crisis we don’t just need COVID-19 vaccines, we also need to ensure that everyone in the world has access to them.

Subscribe to our newsletter